Intestinal Neuroendocrine Tumor — Trials

Intestinal Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00569127	Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor	active not recruiting	Phase 3	427	National Cancer Institute (NCI)NIH	1	Aug 28, 2026	clinicaltrials

Data updated 22 days agoSource updated Aug 28, 2026source: clinicaltrials